Ocugen (OCGN) Depreciation and Depletion (2014 - 2026)

Ocugen (OCGN) posted Depreciation and Depletion of $600000.0 for Q1 2026, little changed on a QoQ basis from $600000.0 in Q1 2025, and little changed year-over-year from $600000.0 in Q1 2025.

Ocugen (OCGN) Depreciation and Depletion (2014 - 2026) Analysis & Trends

Ocugen's Depreciation and Depletion history runs 10 years deep, the most recent figure standing at $600000.0 for Q1 2026.

  • Quarterly Depreciation and Depletion changed 0.0% year-over-year to $600000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 69.05% YoY) and the FY2025 annual result came in at $2.4 million, up 26.32% from the prior year.
  • Depreciation and Depletion was $600000.0 for Q1 2026 at Ocugen, roughly flat from $600000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $600000.0 in Q1 2025 and bottomed at $600000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 196,658.72
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 39.39 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 2.20 Mn
10 Ocugen 63.79 Mn 63.79 Mn - 600,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 600,000.00
Mar 31, 2026 600,000.00
Mar 31, 2025 600,000.00
Mar 31, 2025 600,000.00
Dec 31, 2021 49,000.00
Dec 31, 2021 49,000.00
Sep 30, 2021 100,000.00
Sep 30, 2021 100,000.00
Jun 30, 2021 49,000.00
Jun 30, 2021 49,000.00
Mar 31, 2021 44,000.00
Mar 31, 2021 44,000.00
Dec 31, 2020 42,000.00
Dec 31, 2020 42,000.00
Sep 30, 2020 19,800.00
Sep 30, 2020 19,800.00
Jun 30, 2020 20,000.00
Jun 30, 2020 20,000.00
Mar 31, 2020 18,000.00
Mar 31, 2020 18,000.00